ASX:RMDHealth Care Equipment & ServicesHealth Care Equipment
RESMED CDI
$37.600
+$0.190 (+0.51%)
Day Range
$37.080 - $37.950
52 Week Range
$32.040 - $45.250
Volume
1.21M
Market Cap
$21.79B
Price Chart
Market Statistics
Open$37.200
Previous Close$37.410
Day High$37.950
Day Low$37.080
52 Week High$45.250
52 Week Low$32.040
Valuation
Market Cap21.79B
Shares Outstanding579.45M
Trading Activity
Volume1.21M
Value Traded45.63M
Bid$37.500 × 1,250
Ask$37.660 × 549
Technical Indicators
RSI (14)49.04
50-Day SMA$37.741
200-Day SMA$39.406
Latest News
ASX 200Biotechnology
ResMed delivers double-digit EPS growth on increasing demand for sleep apnoea devices
ResMed (ASX: RMD) has reported double-digit earnings per share (EPS) growth for the three months to March on the back of increasing market demand for its best-in-class sleep apnoea products and software solutions. The company’s revenue for the period increased by 8% to US$1.3 billion (up 9% on a constant currency basis), while income from […]
2 min read
ASX 200Technology
ResMed shares hit as Eli Lilly’s weight loss drug demonstrates sleep apnoea benefits
Medical device maker ResMed (ASX: RMD) saw its shares tumble more than 13% after pharmaceutical rival Eli Lilly announced that its weight-loss drug Zepbound (tirzepatide) could also help resolve sleep apnoea in some patients. California-based ResMed is a giant in the sleep apnoea space, manufacturing face masks, nasal devices and continuous positive airway pressure (PAP) […]
2 min read